SHRUTI PRAVINKUMAR PATEL

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology SACRAMENTO, CA NPI 1376937656

General Payments — all program years on this page

$1,783.94

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 47
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $952.35 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $952.3521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $115.921
2021 $120.191
2022 $25.411
2023 $570.0723
2024 $952.3521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078321051 Janssen Biotech, Inc. $24.61 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078321819 Janssen Biotech, Inc. $27.46 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078321963 Janssen Biotech, Inc. $18.60 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078322085 Janssen Biotech, Inc. $25.05 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202692 ABBVIE INC. $27.56 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202697 ABBVIE INC. $125.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202701 ABBVIE INC. $28.48 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202705 ABBVIE INC. $28.21 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202708 ABBVIE INC. $22.07 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202712 ABBVIE INC. $28.66 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105202717 ABBVIE INC. $15.94 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113642843 Intercept Pharmaceuticals, Inc. $91.08 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114133702 Regeneron Healthcare Solutions, Inc. $21.74 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119293259 Medtronic, Inc. $189.79 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131737528 ARRAY BIOPHARMA INC $138.67 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133792607 Gilead Sciences, Inc. $18.21 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137651374 Takeda Pharmaceuticals U.S.A., Inc. $25.55 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137651376 Takeda Pharmaceuticals U.S.A., Inc. $22.17 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137651378 Takeda Pharmaceuticals U.S.A., Inc. $21.37 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137651380 Takeda Pharmaceuticals U.S.A., Inc. $25.12 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146977276 AIMMUNE THERAPEUTICS, INC. $27.01 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.